Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis

webmaster Tuesday, July 11, 2023

will

The University of Tasmania invites applications for Master of Public Health

webmaster Thursday, March 13, 2025

Dengue

USAID and Takeda Launch Dengue Prevention Campaign

webmaster Friday, July 26, 2024

United States

UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT

webmaster Wednesday, October 21, 2015

Swollen lymph nodes

Monkeypox

webmaster Sunday, August 18, 2024

selected

Excerpts from selected Google Books

webmaster Wednesday, October 09, 2024